Status:
COMPLETED
The Relationship of Sevoflurane Consumption With Metabolic Age
Lead Sponsor:
Inonu University
Conditions:
Sevoflurane
Eligibility:
All Genders
18-65 years
Brief Summary
The aim of this clinical study is to determine the consumption of sevoflurane, which is one of the inhalation anesthetics, with metabolic age and basal metabolic rate. The basal metabolic rates and me...
Detailed Description
Standard monitoring, BIS, TOF (train of four) were performed from the premedication application. Aspect A 2000 (Aspect Medical Systems, Newton) monitor and single-chip BIS electrodes will be used for ...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Between the ages of 18-65 who are scheduled for rhinoplasty or septoplasty with ASA I-II Cases lasting 1 to 3 hours
- Exclude Criteria:
- Patients at high risk of malignant hyperthermia, with a history of allergy to general anesthesia or any of the drugs to be used in the study, accepted as ASA III- ASA IV
Exclusion
Key Trial Info
Start Date :
September 9 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 3 2023
Estimated Enrollment :
79 Patients enrolled
Trial Details
Trial ID
NCT06018597
Start Date
September 9 2022
End Date
March 3 2023
Last Update
August 30 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Inonu universitesi
Malatya, Turkey (Türkiye), 44050